FAB — Fusion Antibodies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Fusion Antibodies, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.05	0.195	1.2	0.359	1.04
Net Total Accounts Receivable
Net Total Receivables	1.02	0.695	0.491	0.488	0.705
Total Inventory
Prepaid Expenses
Total Current Assets	4.28	1.69	2.26	1.35	2.37
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.633	0.375	0.158	0.063	0.355
Net Intangible Assets
Total Assets	4.92	2.06	2.42	1.41	2.73
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.21	0.879	0.584	0.623	0.842
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.23	0.939	0.627	0.654	1.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.68	1.12	1.79	0.756	1.62
Total Liabilities & Shareholders' Equity	4.92	2.06	2.42	1.41	2.73
Total Common Shares Outstanding